I've been working for over 20 years as a bistatistician. I started my professional career at the University of Alcala de Henares in Spain, and I have also worked as a statistician in two public hospitals in Spain and the Spanish Agency for Evaluation of health Technologies. I used to combine my academic work with freelance consultancy and teaching of biostatistics to health professionals. At the moment my work is split between the UK (LSHTM and the Farr Institute of Health Informatics Research at UCL) and Spain, where I lead a group on applied medical statistics at the Catholic University of Murcia (UCAM).
I used to co-ordinate the module on Bayesian Statistics in the Medical Statistics MSc, where I still teach. I also teach basic statistics in the Diploma in Pharmacoepidemiology and the Intensive course in Epidemiology and Medical Statistics.
For several yars I have worked in the development and application of Bayesian Hierarchical Models to the analysis of large databases of pharmacovigilance where I have used extensively the WHO database of adverse drug reactions.
I have also worked in risk prediction modelling and I have developed a risk score for cardiovascular events (ASCORE) and another one for death after traumatic injuries (CRASH-2). I have done some theoretical work on the design and analysis of clinical trials and I have applied this to the analysis of large clinical trials, such as CRASH-2 and WOMAN trials in the Clinical Trials Unit.
Most recently I am developing an interest in statistical and computational methods to use large multidimensional data sets ("big data") for prediction of events and for aethiological research. Among the models that we are considering are: penalised generalised lineal models (and a Bayesian approach to these), multivariate analysis, diferential network analysis and machine learning methods. At the Farr Institute (UCL) I work with electronic health records (CALIBER) of millions of patients and with large databases of genomic, metabolomic and proteomic data (the UCLEB consortium and the UK biobank).